A Functional Virgin Olive Oil Enriched with Olive Oil and Thyme Phenolic Compounds Improves the Expression of Cholesterol Efflux-Related Genes: A Randomized, Crossover, Controlled Trial.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
26 Jul 2019
Historique:
received: 11 07 2019
accepted: 25 07 2019
entrez: 31 7 2019
pubmed: 31 7 2019
medline: 21 1 2020
Statut: epublish

Résumé

The consumption of antioxidant-rich foods such as virgin olive oil (VOO) promotes high-density lipoprotein (HDL) anti-atherogenic capacities. Intake of functional VOOs (enriched with olive/thyme phenolic compounds (PCs)) also improves HDL functions, but the gene expression changes behind these benefits are not fully understood. Our aim was to determine whether these functional VOOs could enhance the expression of cholesterol efflux-related genes. In a randomized, double-blind, crossover, controlled trial, 22 hypercholesterolemic subjects ingested for three weeks 25 mL/day of: (1) a functional VOO enriched with olive oil PCs (500 mg/kg); (2) a functional VOO enriched with olive oil (250 mg/kg) and thyme PCs (250 mg/kg; FVOOT), and; (3) a natural VOO (olive oil PCs: 80 mg/kg, control intervention). We assessed whether these interventions improved the expression of cholesterol efflux-related genes in peripheral blood mononuclear cells by quantitative reverse-transcription polymerase chain reactions. The FVOOT intervention upregulated the expression of

Identifiants

pubmed: 31357534
pii: nu11081732
doi: 10.3390/nu11081732
pmc: PMC6723782
pii:
doi:

Substances chimiques

Biomarkers 0
Olive Oil 0
Phenols 0
Plant Extracts 0
Cholesterol 97C5T2UQ7J

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España
ID : AGL2009-13517-C03-01
Organisme : Ministerio de Economía, Industria y Competitividad, Gobierno de España
ID : AGL2012-40144-C03-01
Organisme : Instituto de Salud Carlos III
ID : CB06/03/0028
Organisme : Instituto de Salud Carlos III
ID : CB07/08/0016
Organisme : Instituto de Salud Carlos III
ID : CD17/00122
Organisme : Instituto de Salud Carlos III
ID : CD17/00233
Organisme : Instituto de Salud Carlos III
ID : JR17/00022
Organisme : Agència de Gestió d'Ajuts Universitaris i de Recerca
ID : 2014-SGR-240
Organisme : Agència de Gestió d'Ajuts Universitaris i de Recerca
ID : 2017-SGR-522

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Free Radic Biol Med. 2004 Apr 1;36(7):838-49
pubmed: 15019969
J Lipid Res. 2004 Dec;45(12):2161-73
pubmed: 15489539
Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):359-65
pubmed: 17110604
FASEB J. 2010 Jul;24(7):2546-57
pubmed: 20179144
J Agric Food Chem. 2012 Mar 28;60(12):3105-12
pubmed: 22380740
Circulation. 2012 Apr 17;125(15):1905-19
pubmed: 22508840
Mol Nutr Food Res. 2012 May;56(5):691-701
pubmed: 22648616
Mol Nutr Food Res. 2012 Jul;56(7):1043-57
pubmed: 22760979
J Nutr Biochem. 2013 Jul;24(7):1334-9
pubmed: 23333095
Nutrients. 2012 Dec 11;4(12):1989-2007
pubmed: 23363996
Mol Nutr Food Res. 2013 May;57(5):760-71
pubmed: 23450515
Cell Cycle. 2013 May 15;12(10):1521-35
pubmed: 23598720
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2115-9
pubmed: 25060792
Mol Nutr Food Res. 2015 Sep;59(9):1758-70
pubmed: 26011257
PLoS One. 2015 Jun 10;10(6):e0129160
pubmed: 26061039
Mol Nutr Food Res. 2015 Sep;59(9):1725-34
pubmed: 26081100
Nutrients. 2015 Sep 11;7(9):7651-75
pubmed: 26378571
Int J Mol Sci. 2016 Mar 22;17(3):429
pubmed: 27011179
Int J Mol Sci. 2016 Jul 05;17(7):
pubmed: 27399675
Molecules. 2016 Dec 16;21(12):
pubmed: 27999296
Nutrients. 2017 Mar 20;9(3):null
pubmed: 28335507
Nutrients. 2017 May 09;9(5):null
pubmed: 28486416
Mol Nutr Food Res. 2017 Oct;61(10):
pubmed: 28544610
Front Pharmacol. 2017 Jun 26;8:380
pubmed: 28694777
Mol Nutr Food Res. 2017 Dec;61(12):
pubmed: 28887843
Nutrients. 2017 Sep 30;9(10):null
pubmed: 28973999
J Nutr Biochem. 2018 Jan;51:99-104
pubmed: 29125992
Nutrients. 2018 May 16;10(5):null
pubmed: 29772657
Mol Nutr Food Res. 2018 May 26;:e1800011
pubmed: 29802792
Mol Nutr Food Res. 2018 Aug;62(16):e1800456
pubmed: 29956886
Crit Rev Food Sci Nutr. 2019;59(6):893-920
pubmed: 30421983
Circ Res. 2019 Mar;124(5):779-798
pubmed: 30817261
Nutrients. 2019 Mar 06;11(3):null
pubmed: 30845690

Auteurs

Marta Farràs (M)

Molecular Bases of Cardiovascular Risk Group, IIB-Sant Pau, 08041 Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), ISCIII, 28029 Madrid, Spain.

Sara Arranz (S)

Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.

Sílvia Carrión (S)

Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.

Isaac Subirana (I)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Cardiovascular Genetics and Epidemiology Research Group, IMIM, 08003 Barcelona, Spain.

Daniel Muñoz-Aguayo (D)

Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), ISCIII, 28029 Madrid, Spain.

Gemma Blanchart (G)

Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.

Marjon Kool (M)

Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.

Rosa Solà (R)

Functional Nutrition, Oxidation, and Cardiovascular Diseases Group, Universitat Rovira i Virgili, 43201 Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili, 43204 Reus, Spain.
Hospital Universitari Sant Joan de Reus, 43204 Reus, Spain.

María José Motilva (MJ)

Instituto de Ciencias de la Vid y el Vino, CSIC-Universidad de la Rioja, 26007 Logroño, Spain.

Joan Carles Escolà-Gil (JC)

Molecular Bases of Cardiovascular Risk Group, IIB-Sant Pau, 08041 Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), ISCIII, 28029 Madrid, Spain.

Laura Rubió (L)

Food Technology Department, Agrotecnio Center, University of Lleida, 25198 Lleida, Spain.

Sara Fernández-Castillejo (S)

Functional Nutrition, Oxidation, and Cardiovascular Diseases Group, Universitat Rovira i Virgili, 43201 Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili, 43204 Reus, Spain.

Anna Pedret (A)

Functional Nutrition, Oxidation, and Cardiovascular Diseases Group, Universitat Rovira i Virgili, 43201 Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili, 43204 Reus, Spain.

Ramón Estruch (R)

CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), ISCIII, 28029 Madrid, Spain.
Internal Medicine Service, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
Cardiovascular Risk, Nutrition and Aging Research Unit, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.

María Isabel Covas (MI)

CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), ISCIII, 28029 Madrid, Spain.
NUPROAS Handelsbolag, Nackă, Sweden.

Montserrat Fitó (M)

Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.
CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), ISCIII, 28029 Madrid, Spain.

Álvaro Hernáez (Á)

CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), ISCIII, 28029 Madrid, Spain. alvaro.hernaez1@gmail.com.
Cardiovascular Risk, Nutrition and Aging Research Unit, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain. alvaro.hernaez1@gmail.com.

Olga Castañer (O)

Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain. ocastaner@imim.es.
CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), ISCIII, 28029 Madrid, Spain. ocastaner@imim.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH